Patent US3258595A successfully refreshed from Google Patents.
Patent US4263245A successfully refreshed from Google Patents.
US4263245A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Process for producing high-strength, ultralow denier polybenzimidazole (PBI) filaments
Assignee: Celanese Corp
•
Filing: 1979-04-23
•
Granted: 1981-04-21
•
Expires: 1999-04-23
Abstract
Abstract An improved process for the production of ultralow denier, high-strength polybenzimidazole filaments is provided. A solution of the polymer is extruded vertically downward through a plurality of extrusion orifices into a gaseous atmosphere before being passed through a liquid coagulation bath. During their passage from the extrusion orifices to the exit from the coagulation bath, the filaments are drawn at an initial draw ratio of approximately 2:1 to 50:1. After being passed through the coagulaton bath, the filaments are washed, dried, and heat drawn at a heat draw ratio of approximately 1.5:1 to 10:1. The resulting filaments, having a denier per filament of approximately 0.05 to 0.50 and a tenacity of at least 4 grams per denier, are collected.
Inventors
- 👤 Marshall Tan
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-24 12:35
CPC Classifications
D; D01; D01F; D01F6/00; D01F6/58; D01F6/74; D01D; D01D5/00; D01D5/12
Claims Analysis
Total Claims: 33
Claim 1
Independent Claim
270 words
A process for the stable production of high strength polybenzimidazole filaments of ultralow denier comprising: (a) providing a spinning solution comprising approximately 10 to 30 percent by weight of a polybenzimidazole in a solvent selected from the group consisting of dimethylacetamide, dimethylformamide, dimethylsulfoxide, and concentrated sulfuric acid, (b) extruding said spinning solution vertically downward into a gaseous atmosphere following passage through a plurality of extrusion orifices having a diameter of approximately 20 to 200 microns to form a plurality of filaments with the concomitant drawing of said filaments, (c) passing said resulting filaments from said gaseous atmosphere to a bath comprising a non-solvent for said polybenzimidazole, (d) passing said filaments through said bath wherein (i) coagulation of said polybenzimidazole is accomplished, and (ii) the drawing of said filaments is continued, with an initial draw ratio of approximately 2:1 to 50:1 being achieved, (e) passing said filaments from said bath to a washing zone, (f) washing said resulting filaments while passing through said washing zone to substantially remove residual solvent, (g) passing said filaments from said washing zone to a drying zone, (h) drying said filaments while passing through said drying zone, (i) passing said filaments from said drying zone to a drawing zone provided at a temperature of approximately 400° to 500° C., (j) drawing said filaments while passing through said drawing zone at a heat draw ratio of approximately 1.5:1 to 10:1 to produce polybenzimidazole filaments having a denier per filament of approximately 0.05 to 0.5 and a tenacity of at least 4 grams per denier, and (k) collecting said ultraflow denier filaments following withdrawal from said drawing zone.
Claim 2
Dependent Claim
270 words
A process for the stable production of high strength polybenzimidazole filaments of ultralow denier comprising: (a) providing a spinning solution comprising approximately 10 to 30 percent by weight of a polybenzimidazole in a solvent selected from the group consisting of dimethylacetamide, dimethylformamide, dimethylsulfoxide, and concentrated sulfuric acid, (b) extruding said spinning solution vertically downward into a gaseous atmosphere following passage through a plurality of extrusion orifices having a diameter of approximately 20 to 200 microns to form a plurality of filaments with the concomitant drawing of said filaments, (c) passing said resulting filaments from said gaseous atmosphere to a bath comprising a non-solvent for said polybenzimidazole, (d) passing said filaments through said bath wherein (i) coagulation of said polybenzimidazole is accomplished, and (ii) the drawing of said filaments is continued, with an initial draw ratio of approximately 2:1 to 50:1 being achieved, (e) passing said filaments from said bath to a washing zone, (f) washing said resulting filaments while passing through said washing zone to substantially remove residual solvent, (g) passing said filaments from said washing zone to a drying zone, (h) drying said filaments while passing through said drying zone, (i) passing said filaments from said drying zone to a drawing zone provided at a temperature of approximately 400° to 500° C., (j) drawing said filaments while passing through said drawing zone at a heat draw ratio of approximately 1.5:1 to 10:1 to produce polybenzimidazole filaments having a denier per filament of approximately 0.05 to 0.5 and a tenacity of at least 4 grams per denier, and (k) collecting said ultraflow denier filaments following withdrawal from said drawing zone.
Claim 3
Dependent Claim
91 words
A process according to claim 1 wherein said polybenzimidazole polymer consists essentially of recurring units of the formula ##STR4## wherein R is a tetravalent aromatic nucleus, with the nitrogen atoms forming the benzimidazole rings paired upon adjacent carbon atoms of said aromatic nucleus, and R' is selected from the group consisting of (1) an aromatic ring, (2) an alkylene group having from 4 to 8 carbon atoms, and (3) a heterocyclic ring selected from the group consisting of (a) pyridine, (b) pyrazine, (c) furan, (d) quinoline, (e) thiophene, and (f) pyran.
Claim 4
Dependent Claim
12 words
A process according to claim 1 wherein said polybenzimidazole polymer is poly-2,2'-(m-phenylene)-5,5'-bibenzimidazole.
Claim 5
Dependent Claim
31 words
A process according to claim 1 wherein said solution of said polybenzimidazole prior to extrusion includes approximately 0.1 to 5 percent lithium chloride, based upon the total weight of said solution.
Claim 6
Dependent Claim
14 words
A process according to claim 1 wherein the solvent for said solution comprises dimethylacetamide.
Claim 7
Dependent Claim
22 words
A process according to claim 1 wherein said extrusion orifices are situated approximately one-half inch to 10 inches above said coagulation bath.
Claim 8
Dependent Claim
20 words
A process according to claim 1 wherein said solution is extruded at a temperature of approximately 130° to 150° C.
Claim 9
Dependent Claim
19 words
A process according to claim 1 wherein said extrusion orifices have a diameter of approximately 30 to 50 microns.
Claim 10
Dependent Claim
29 words
A process according to claim 1 wherein said gaseous atmosphere comprises an inert gas selected from the group consisting of nitrogen, the noble gases, steam, combustion gases, and air.
Claim 11
Dependent Claim
12 words
A process according to claim 1 wherein said gaseous atmosphere comprises air.
Claim 12
Dependent Claim
13 words
A process according to claim 1 wherein said liquid coagulation bath comprises water.
Claim 13
Dependent Claim
24 words
A process according to claim 1 wherein said liquid coagulation bath comprises a mixture of approximately 50 percent water and approximately 50 percent dimethylacetamide.
Claim 14
Dependent Claim
22 words
A process according to claim 1 wherein said liquid coagulation bath is maintained at a temperature of approximately 15° to 25° C.
Claim 15
Dependent Claim
16 words
A process according to claim 1 wherein said initial draw ratio is approximately 2:1 to 10:1.
Claim 16
Dependent Claim
22 words
A process according to claim 1 wherein said filaments are washed with water at a temperature of approximately 55° to 65° C.
Claim 17
Dependent Claim
16 words
A process according to claim 1 wherein said heat draw ratio is approximately 3:1 to 6:1.
Claim 18
Dependent Claim
274 words
A process for the stable production of high strength polybenzimidazole filaments of ultralow denier comprising: (a) providing a spinning solution comprising approximately 22 to 26 percent by weight of a polybenzimidazole, approximately 1 to 4 percent by weight of lithium chloride, and approximately 70 to 77 percent by weight of dimethylacetamide, (b) extruding said spinning solution vertically downward into a gaseous atmosphere comprising air following passage through a plurality of extrusion orifices having a diameter of approximately 30 to 50 microns to form a plurality of filaments with the concomitant drawing of said filaments, (c) passing said resulting filaments from said gaseous atmosphere to a bath comprising water, (d) passing said filaments through said bath wherein (i) coagulation of said polybenzimidazole is accomplished, and (ii) the drawing of said filaments is continued, with an initial draw ratio of approximately 2:1 to 10:1 being achieved, (e) passing said filaments from said bath to a washing zone, (f) washing said resulting filaments with water while passing through said washing zone to substantially remove residual solvent, (g) passing said filaments from said washing zone to a drying zone, (h) drying said filaments while passing through said drying zone, (i) passing said filaments from said drying zone to a drawing zone provided at a temperature of approximately 400° to 500° C., (j) drawing said filaments while passing through said drawing zone at a heat draw ratio of approximately 3:1 to 6:1 to produce polybenzimidazole filaments having a denier per filament of approximately 0.05 to 0.5 and a tenacity of at least 4 grams per denier, and (k) collecting said ultralow denier filaments following withdrawal from said drawing zone.
Claim 19
Dependent Claim
274 words
A process for the stable production of high strength polybenzimidazole filaments of ultralow denier comprising: (a) providing a spinning solution comprising approximately 22 to 26 percent by weight of a polybenzimidazole, approximately 1 to 4 percent by weight of lithium chloride, and approximately 70 to 77 percent by weight of dimethylacetamide, (b) extruding said spinning solution vertically downward into a gaseous atmosphere comprising air following passage through a plurality of extrusion orifices having a diameter of approximately 30 to 50 microns to form a plurality of filaments with the concomitant drawing of said filaments, (c) passing said resulting filaments from said gaseous atmosphere to a bath comprising water, (d) passing said filaments through said bath wherein (i) coagulation of said polybenzimidazole is accomplished, and (ii) the drawing of said filaments is continued, with an initial draw ratio of approximately 2:1 to 10:1 being achieved, (e) passing said filaments from said bath to a washing zone, (f) washing said resulting filaments with water while passing through said washing zone to substantially remove residual solvent, (g) passing said filaments from said washing zone to a drying zone, (h) drying said filaments while passing through said drying zone, (i) passing said filaments from said drying zone to a drawing zone provided at a temperature of approximately 400° to 500° C., (j) drawing said filaments while passing through said drawing zone at a heat draw ratio of approximately 3:1 to 6:1 to produce polybenzimidazole filaments having a denier per filament of approximately 0.05 to 0.5 and a tenacity of at least 4 grams per denier, and (k) collecting said ultralow denier filaments following withdrawal from said drawing zone.
Claim 20
Dependent Claim
91 words
A process according to claim 17 wherein said polybenzimidazole polymer consists essentially of recurring units of the formula: ##STR5## wherein R is a tetravalent aromatic nucleus, with the nitrogen atoms forming the benzimidazole rings paired upon adjacent carbon atoms of said aromatic nucleus, and R' is selected from the group consisting of (1) an aromatic ring, (2) an alkylene group having from 4 to 8 carbon atoms, and (3) a heterocyclic ring selected from the group consisting of (a) pyridine, (b) pyrazine, (c) furan, (d) quinoline, (e) thiophene, and (f) pyran.
Claim 21
Dependent Claim
12 words
A process according to claim 17 wherein said polybenzimidazole polymer is poly-2,2'-(m-phenylene)-5,5'-bibenzimidazole.
Claim 22
Dependent Claim
20 words
A process according to claim 17 wherein said solution is extruded at a temperature of approximately 130° to 150° C.
Claim 23
Dependent Claim
20 words
A process according to claim 17 wherein said extrusion orifices are situated approximately 5 to 7 inches above said bath.
Claim 24
Dependent Claim
21 words
A process according to claim 17 wherein said coagulation bath is maintained at a temperature of approximately 15° to 25° C.
Claim 25
Dependent Claim
16 words
A process according to claim 17 wherein said initial draw ratio is approximately 3:1 to 3.5:1.
Claim 26
Dependent Claim
19 words
A process according to claim 17 wherein said filaments are washed with water at approximately 55° to 65° C.
Claim 27
Dependent Claim
16 words
A process according to claim 17 wherein said heat draw ratio is approximately 3:1 to 3.5:1.
Claim 28
Dependent Claim
270 words
A process for the stable production of high strength polybenzimidazole filaments of ultralow denier comprising: (a) providing a spinning solution comprising approximately 23 percent by weight poly-2,2'-(m-phenylene)-5,5'-bibenzimidazole, approximately 2 percent by weight lithium chloride, and approximately 75 percent by weight dimethylacetamide, (b) extruding said spinning solution vertically downward into a gaseous atmosphere comprising air following passage through a plurality of extrusion orifices having a diameter of approximately 30 to 50 microns to form a plurality of filaments with the concomitant drawing of said filaments, (c) passing said resulting filaments from said gaseous atmosphere to a bath comprising water, (d) passing said filaments through said bath wherein (i) coagulation of the polybenzimidazole is accomplished and (ii) the drawing of said filaments is continued, with an initial draw ratio of 3:1 to 3.5:1 being achieved, (e) passing said filaments from said bath to a washing zone, (f) washing said resulting filaments with water at approximately 55° to 65° C. while passing through said washing zone to substantially remove residual solvent, (g) passing said filaments from said washing zone to a drying zone, (h) drying said filaments while passing through said drying zone, (i) passing said filaments from said drying zone to a drawing zone provided at a temperature of approximately 400° C. to 500° C., (j) drawing said filaments while passing through said drawing zone at a heat draw ratio of approximately 3:1 to 3.5:1 to produce polybenzimidazole filaments having a denier per filament of approximately 0.05 to 0.5 and a tenacity of at least 4 grams per denier, and (k) collecting said ultralow denier filaments following withdrawal from said drawing zone.
Claim 29
Dependent Claim
270 words
A process for the stable production of high strength polybenzimidazole filaments of ultralow denier comprising: (a) providing a spinning solution comprising approximately 23 percent by weight poly-2,2'-(m-phenylene)-5,5'-bibenzimidazole, approximately 2 percent by weight lithium chloride, and approximately 75 percent by weight dimethylacetamide, (b) extruding said spinning solution vertically downward into a gaseous atmosphere comprising air following passage through a plurality of extrusion orifices having a diameter of approximately 30 to 50 microns to form a plurality of filaments with the concomitant drawing of said filaments, (c) passing said resulting filaments from said gaseous atmosphere to a bath comprising water, (d) passing said filaments through said bath wherein (i) coagulation of the polybenzimidazole is accomplished and (ii) the drawing of said filaments is continued, with an initial draw ratio of 3:1 to 3.5:1 being achieved, (e) passing said filaments from said bath to a washing zone, (f) washing said resulting filaments with water at approximately 55° to 65° C. while passing through said washing zone to substantially remove residual solvent, (g) passing said filaments from said washing zone to a drying zone, (h) drying said filaments while passing through said drying zone, (i) passing said filaments from said drying zone to a drawing zone provided at a temperature of approximately 400° C. to 500° C., (j) drawing said filaments while passing through said drawing zone at a heat draw ratio of approximately 3:1 to 3.5:1 to produce polybenzimidazole filaments having a denier per filament of approximately 0.05 to 0.5 and a tenacity of at least 4 grams per denier, and (k) collecting said ultralow denier filaments following withdrawal from said drawing zone.
Claim 30
Dependent Claim
20 words
A process according to claim 26 wherein said solution is extruded at a temperature of approximately 130° to 150° C.
Claim 31
Dependent Claim
17 words
A process according to claim 26 wherein said extrusion orifices have a diameter of approximately 40 microns.
Claim 32
Dependent Claim
18 words
A process according to claim 26 wherein said extrusion orifices are situated approximately 7 inches above said bath.
Claim 33
Dependent Claim
21 words
A process according to claim 26 wherein said coagulation bath is maintained at a temperature of approximately 15° to 25° C.
References Cited (Backward Citations)
US3079219A
Cited
US3414645A
Cited
US3441640A
Cited
US3584104A
Cited
US3619453A
Cited
US3642706A
Cited
US3816581A
Cited
US3836621A
Cited
US3851025A
Cited
JPS5048217A
Cited
US4020142A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1984-04-20 | 1984-10-20 | 1985-04-21 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1988-04-20 | 1988-10-20 | 1989-04-21 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1992-04-20 | 1992-10-20 | 1993-04-21 | $7700.00 | Window Closed / Lapsed |